Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - emtricitabinum, tenofovirum alafenamidum - filmtabletten - emtricitabinum 200 mg, tenofovirum alafenamidum 10 mg zu tenofoviri alafenamidi hemifumaras, cellulosum microcristallinum, carmellosum natricum nur zusammengehalten, magnesium stearas, Überzug: poly(alkohol vinylicus), macrogolum 3350, talkum, e 171, e-172 (schwarz), für compresso haze endwerte. natrium 2,7 mg. - hiv-infektion - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - emtricitabinum, tenofovirum alafenamidum - filmtabletten - emtricitabinum 200 mg, tenofovirum alafenamidum 25 mg zu tenofoviri alafenamidi hemifumaras, cellulosum microcristallinum, carmellosum natricum nur zusammengehalten, magnesium stearas, Überzug: poly(alkohol vinylicus), macrogolum 3350, talkum, e 171, e 132, für compresso haze endwerte. natrium 2.6 mg. - hiv-infektion - synthetika

Europäische Union - Deutsch - EMA (European Medicines Agency)

gilead sciences ireland uc - emtricitabin, tenofovir alafenamide - hiv-infektionen - antivirale mittel zur systemischen anwendung - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv-1).